HARBOUR INVESTMENTS, INC. - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 228 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
HARBOUR INVESTMENTS, INC. ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,949
-51.3%
2,2000.0%0.00%
Q3 2022$4,0000.0%2,2000.0%0.00%
Q2 2022$4,000
-33.3%
2,200
+83.3%
0.00%
Q4 2021$6,000
-88.7%
1,200
-82.6%
0.00%
-100.0%
Q3 2021$53,000
-19.7%
6,898
+1.1%
0.00%0.0%
Q2 2021$66,000
+13.8%
6,824
-2.8%
0.00%0.0%
Q1 2021$58,0007,0210.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 15,001$1,4100.00%
KLCM Advisors, Inc. 20,000$1,8800.00%
AlphaMark Advisors, LLC 3,135$00.00%
TRUST CO OF VERMONT 204$190.00%
SlateStone Wealth, LLC 30,866$30.00%
Coppell Advisory Solutions LLC 100$890.00%
Highlander Capital Management, LLC 1,200$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Russell Investments Group, Ltd. 266$250.00%
OGOREK ANTHONY JOSEPH /NY/ /ADV 3,600$00.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders